AlloSeq HCT
Revolutionising Engraftment Monitoring
AlloSeq HCT is a targeted NGS-based solution enabling precise measurement of engraftment following hematopoietic stem cell transplant. The latest innovation in chimerism testing that is able to determine the relative contribution of up to 3 genomes in a single sample i.e. up to two donors per recipient.
To Request a Demo
Benefits of AlloSeq HCT
Assay
- 1 assay for genotyping and monitoring
- 1-step single reaction multiplexed PCR
- Highly sensitive – 0.22% limit of detection
- Accurate, precise, and reproducible results
- Streamlined workflow with minimal hands-on time within 3 hours
HCT Software
- Able to determine and automatically compare up to 3 genotypes in a single sample – donor(s) and recipient: useful for cord blood transplants
- User-friendly AlloSeq HCT software features automatic determination of informative loci, chimerism calculation, and result tracking
For Full Details Visit
Ordering Details
To discuss your purchase requirements in complete confidence, please
Contact
us using our secure enquiry form, and one of our management team will get back in touch.
